Prevention and Early Detection Clinical Trials: Opportunities for Primary Care Providers and Their Patients

Enrollment into cancer prevention and early detection clinical trials represents a unique challenge compared with a diagnostic or treatment trial because it involves subjects without a diagnosis of cancer. This paper examines some of the barriers to participation in prevention and early detection trials and provides detailed information about two ongoing prevention and two ongoing early detection clinical trials open to enrollment as well as brief summaries of seven additional trials now open to enrollment.

[1]  P. Walsh.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2003, The Journal of urology.

[2]  John Eng,et al.  Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. , 2003, JAMA.

[3]  C. D'Orsi,et al.  Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer. , 2002, AJR. American journal of roentgenology.

[4]  P. Albertsen.  Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. , 2002, The Journal of urology.

[5]  Patrick C. Walsh,et al.  American Cancer Society guidelines for the early detection of cancer. , 2002, CA: a cancer journal for clinicians.

[6]  D. Wysowski,et al.  Uterine sarcoma associated with tamoxifen use. , 2002, The New England journal of medicine.

[7]  J. Bryant,et al.  Association of tamoxifen and uterine sarcoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Ahmedin Jemal,et al.  Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.

[9]  T. Brennan,et al.  Direct-to-consumer marketing of high-technology screening tests. , 2002, The New England journal of medicine.

[10]  G Bartsch,et al.  Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. , 2001, Urology.

[11]  J. Gohagan,et al.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. , 2000, Controlled clinical trials.

[12]  S. Swensen,et al.  Screening for lung cancer with low-dose spiral computed tomography. , 2000, American journal of respiratory and critical care medicine.

[13]  L. Tabár,et al.  The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.

[14]  Andrew D. A. Maidment,et al.  Current status of full-field digital mammography. , 2000, Academic radiology.

[15]  R. Tarone,et al.  Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates. , 2000, Epidemiology.

[16]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[17]  I. Smith.  Screening for lung cancer: time to think positive , 1999, The Lancet.

[18]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[19]  N. Sadick,et al.  Estrogen and progesterone receptors: their role in postsclerotherapy angiogenesis telangiectatic matting (TM). , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  S. Cummings,et al.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. , 1999, JAMA.

[21]  G. Strauss,et al.  Varese meeting report. , 1999, Lung cancer.

[22]  M. Morrow,et al.  Results of Hospital Cancer Registry Surveys by the American College of Surgeons. Outcomes of Prostate Cancer Treatment by Radical Prostatectomy , 1998 .

[23]  M. Morrow,et al.  Results of hospital cancer registry surveys by the American College of Surgeons , 1997, Cancer.

[24]  A. Leitch,et al.  American Cancer Society guidelines for the early detection of breast cancer: Update 1997 , 1997, CA: a cancer journal for clinicians.

[25]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[26]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[27]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[28]  C. Redmond,et al.  A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.

[29]  N. Day,et al.  TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES , 1987, The Lancet.

[30]  S. Shapiro,et al.  Periodic breast cancer screening in reducing mortality from breast cancer. , 1971, JAMA.

[31]  T. Powles,et al.  Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial , 2004, Breast Cancer Research and Treatment.

[32]  E. Platz,et al.  Selenium, zinc, and prostate cancer. , 2001, Epidemiologic reviews.

[33]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[34]  L. Newman,et al.  COMMITTEE ON TECHNOLOGIES FOR THE EARLY DETECTION OF BREAST CANCER , 2000 .

[35]  B W Turnbull,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. , 1996, JAMA.

[36]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[37]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[38]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.

[39]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.